The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors

Abstract Objective To explore the application of neutrophils to lymphocytes ratio (NLR), platelet to lymphocyte ratio (PLR) and monocyte to lymphocyte ratio (MLR) in the differential diagnosis of benign uterine diseases and endometrial malignant tumors. Methods 80 patients with endometrial malignant...

Full description

Bibliographic Details
Main Author: Lin Qin
Format: Article
Language:English
Published: Springer 2024-03-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-024-00956-8
_version_ 1827301133545111552
author Lin Qin
author_facet Lin Qin
author_sort Lin Qin
collection DOAJ
description Abstract Objective To explore the application of neutrophils to lymphocytes ratio (NLR), platelet to lymphocyte ratio (PLR) and monocyte to lymphocyte ratio (MLR) in the differential diagnosis of benign uterine diseases and endometrial malignant tumors. Methods 80 patients with endometrial malignant tumor diagnosed in our hospital from January 2019 to December 2022 were selected as the study group, and 74 patients with benign uterine diseases confirmed by pathology in our hospital during the same period were randomly selected as the control group. The differences of NLR, PLR and MLR in the peripheral blood of patients in each group were compared, and the value of individual indicators in the diagnosis of endometrial malignant tumor was evaluated using the Receiver Operating Characteristic (ROC) curve. Results In peripheral blood, the NLR, PLR and MLR value in patients with endometrial cancer (EC) were significantly higher than those in patients with benign uterine diseases (P < 0.05). The area under the curve (AUC) of NLR, PLR, MLR in peripheral blood were 0.777, 0. 675 and 0.698. The best cutoff values were 2.02, 132.06 and 0.166. The sensitivity and specificity were 62.5% and 79.7%, 62.5% and 63.5%, 81 3% and 47.3%. The combination of these three indicators can significantly improved the diagnostic efficiency in endometrial cancer (AUC = 0.780), and the sensitivity and specificity were 60% and 83.8%. Conclusions In peripheral blood, NLR, PLR and MLR have certain diagnostic value in the differential diagnosis of endometrial cancer. When NLR, PLR and MLR are elevated, we should be alert to the occurrence of endometrial malignant tumors, and the combined diagnostic efficiency is high.
first_indexed 2024-04-24T16:16:50Z
format Article
id doaj.art-aba4483cbdae4657ac5ab320f8dcbfa5
institution Directory Open Access Journal
issn 2730-6011
language English
last_indexed 2024-04-24T16:16:50Z
publishDate 2024-03-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj.art-aba4483cbdae4657ac5ab320f8dcbfa52024-03-31T11:24:18ZengSpringerDiscover Oncology2730-60112024-03-011511710.1007/s12672-024-00956-8The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumorsLin Qin0Senior Department of Obstetrics & Gynecology, The Seventh Medical Center of PLA General HospitalAbstract Objective To explore the application of neutrophils to lymphocytes ratio (NLR), platelet to lymphocyte ratio (PLR) and monocyte to lymphocyte ratio (MLR) in the differential diagnosis of benign uterine diseases and endometrial malignant tumors. Methods 80 patients with endometrial malignant tumor diagnosed in our hospital from January 2019 to December 2022 were selected as the study group, and 74 patients with benign uterine diseases confirmed by pathology in our hospital during the same period were randomly selected as the control group. The differences of NLR, PLR and MLR in the peripheral blood of patients in each group were compared, and the value of individual indicators in the diagnosis of endometrial malignant tumor was evaluated using the Receiver Operating Characteristic (ROC) curve. Results In peripheral blood, the NLR, PLR and MLR value in patients with endometrial cancer (EC) were significantly higher than those in patients with benign uterine diseases (P < 0.05). The area under the curve (AUC) of NLR, PLR, MLR in peripheral blood were 0.777, 0. 675 and 0.698. The best cutoff values were 2.02, 132.06 and 0.166. The sensitivity and specificity were 62.5% and 79.7%, 62.5% and 63.5%, 81 3% and 47.3%. The combination of these three indicators can significantly improved the diagnostic efficiency in endometrial cancer (AUC = 0.780), and the sensitivity and specificity were 60% and 83.8%. Conclusions In peripheral blood, NLR, PLR and MLR have certain diagnostic value in the differential diagnosis of endometrial cancer. When NLR, PLR and MLR are elevated, we should be alert to the occurrence of endometrial malignant tumors, and the combined diagnostic efficiency is high.https://doi.org/10.1007/s12672-024-00956-8Endometrial cancerNLRPLRMLR
spellingShingle Lin Qin
The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
Discover Oncology
Endometrial cancer
NLR
PLR
MLR
title The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
title_full The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
title_fullStr The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
title_full_unstemmed The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
title_short The predictive value of NLR, PLR and MLR in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
title_sort predictive value of nlr plr and mlr in the differential diagnosis of benign uterine diseases and endometrial malignant tumors
topic Endometrial cancer
NLR
PLR
MLR
url https://doi.org/10.1007/s12672-024-00956-8
work_keys_str_mv AT linqin thepredictivevalueofnlrplrandmlrinthedifferentialdiagnosisofbenignuterinediseasesandendometrialmalignanttumors
AT linqin predictivevalueofnlrplrandmlrinthedifferentialdiagnosisofbenignuterinediseasesandendometrialmalignanttumors